Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tonix Pharmaceuticals Holding (TNXP) Inventory Average (2023 - 2025)

Historic Inventory Average for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $5.9 million.

  • Tonix Pharmaceuticals Holding's Inventory Average fell 3262.59% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year decrease of 3262.59%. This contributed to the annual value of $11.0 million for FY2024, which is N/A changed from last year.
  • Tonix Pharmaceuticals Holding's Inventory Average amounted to $5.9 million in Q3 2025, which was down 3262.59% from $7.1 million recorded in Q2 2025.
  • Over the past 5 years, Tonix Pharmaceuticals Holding's Inventory Average peaked at $13.5 million during Q3 2023, and registered a low of $5.9 million during Q3 2025.
  • For the 3-year period, Tonix Pharmaceuticals Holding's Inventory Average averaged around $9.9 million, with its median value being $8.7 million (2024).
  • As far as peak fluctuations go, Tonix Pharmaceuticals Holding's Inventory Average tumbled by 3943.36% in 2024, and later plummeted by 3262.59% in 2025.
  • Quarter analysis of 3 years shows Tonix Pharmaceuticals Holding's Inventory Average stood at $13.5 million in 2023, then tumbled by 39.43% to $8.2 million in 2024, then fell by 28.3% to $5.9 million in 2025.
  • Its Inventory Average stands at $5.9 million for Q3 2025, versus $7.1 million for Q2 2025 and $8.3 million for Q1 2025.